MindBio Therapeutics Corp., a biotechnology company developing artificial intelligence-driven voice analytics for drug and alcohol intoxication detection, has completed the manufacturing of its next-generation Edge AI Intoxication Detection Kiosk. The announcement marks a significant step toward commercializing a rapid, non-invasive alternative to conventional drug and alcohol screening methods.
The new hardware builds on a prototype developed in June and is designed to support the company's proprietary Voice AI technology, which analyzes vocal characteristics to identify potential impairment. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is continuing software integration, system testing and validation of its predictive models against conventional breath alcohol and oral fluid testing methods, with a potential initial commercial pilot targeted for later this year.
The kiosk is being developed as a rapid, non-invasive alternative to conventional drug and alcohol screening, targeting safety-sensitive industries including mining, aviation, construction, heavy transport and law enforcement. MindBio aims to enable more frequent, large-scale workplace screening while potentially reducing testing costs, administration time and operational disruptions. The planned commercial pilot would provide an opportunity to evaluate the technology's performance in a real-world environment against existing testing methods.
MindBio's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
For investors seeking the latest news and updates relating to MBQIF, the company's newsroom is available at https://ibn.fm/MBQIF. To view the full press release, visit https://ibn.fm/UN9LN.
The announcement was disseminated through TechMediaWire, a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries, among other services. The full terms of use and disclaimers applicable to all content provided by TMW are available at https://www.TechMediaWire.com/Disclaimer.
The completion of manufacturing and the forthcoming pilot represent a potential shift in workplace safety and impairment detection. If validated, the technology could offer employers a faster, less intrusive method to screen for intoxication, potentially increasing screening frequency and improving safety outcomes in high-risk industries. For investors, the progress signals advancement toward commercialization, though regulatory and adoption hurdles remain.
